Adynxx

About:

Adynxx is a biopharmaceutical company that develops pain management drugs.

Top Investors: Domain Associates, TPG Biotech

Description:

Adynxx a biopharmaceutical company, develops pain management drugs. It offers AYX1, a drug candidate to prevent acute post-operative pain and its transition into chronic pain; and AYX therapeutic programs, including long-term relief treatments for mature chronic pain syndromes. The company was incorporated in 2007 and is based in San Francisco, California.

Total Funding Amount:

$23.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)adynxxinc.com

Founders:

Julien Mamet

Number of Employees:

101-250

Last Funding Date:

2017-01-10

IPO Status:

Private

Industries: